Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 12,584 million in 2023 by DelveInsight
Chronic Obstructive Pulmonary Disease companies are Afimmune, Allakos, Amgen/AstraZeneca, Arrowhead Pharmaceuticals, Zydus Lifesciences, Astellas, AstraZeneca. ALBANY, NEW YORK, UNITED STATES, May 30, 2024 /EINPresswire.com/ -- DelveInsight…